Search Results

Results of the randomised phase II NCRI arctic (attenuated dose rituximab with chemotherapy in CLL) trial of low dose rituximab in previously untreated CLL

by Munir, T, Cohen, D, Milligan, D, Schuh, A, McParland, L, Chalmers, A, Varghese, A, Rawstron, A, Allsup, D, Marshall, S, Smith, A, Collett, C, Gregory, W, Duncombe, A, Hillmen, P
Published 2016

Clinical effectiveness and cost-effectiveness results from the randomised, Phase IIB trial in previously untreated patients with chronic lymphocytic leukaemia to compare fludarabine, cyclophosphamide and rituximab with fludarabine, cyclophosphamide, mitoxantrone and low-dose rituximab: the Attenuated dose...

by Howard, DR, Munir, T, McParland, L, Rawstron, AC, Chalmers, A, Gregory, WM, O'Dwyer, JL, Smith, A, Longo, R, Varghese, A, Hillmen, P
Published 2017

Clinical effectiveness and cost-effectiveness results from the randomised, Phase IIB trial in previously untreated patients with chronic lymphocytic leukaemia to compare fludarabine, cyclophosphamide and rituximab with fludarabine, cyclophosphamide, mitoxantrone and low-dose rituximab: the Attenuated dose...

by Howard, Dena R, Munir, Talha, McParland, Lucy, Rawstron, Andy C, Chalmers, Anna, Gregory, Walter M, O'Dwyer, John L, Smith, Alison, Longo, Roberta, Varghese, Abraham, Smith, Alexandra, Hillmen, Peter
Published in Health Technology Assessment (2017)

Clinical effectiveness and cost-effectiveness results from the randomised, Phase IIB trial in previously untreated patients with chronic lymphocytic leukaemia to compare fludarabine, cyclophosphamide and rituximab with fludarabine, cyclophosphamide, mitoxantrone and low-dose rituximab: the Attenuated dose...

by Dena R Howard, Talha Munir, Lucy McParland, Andy C Rawstron, Anna Chalmers, Walter M Gregory, John L O’Dwyer, Alison Smith, Roberta Longo, Abraham Varghese, Alexandra Smith, Peter Hillmen
Published in Health Technology Assessment (2017)

Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLL.

by Howard, D R, Munir, T, McParland, L, Rawstron, A C, Milligan, D, Schuh, A, Hockaday, A, Allsup, D J, Marshall, S, Duncombe, A S, O'Dwyer, J L, Smith, A F, Longo, R, Varghese, A, Hillmen, P
Published in Leukemia (2017)

Results of the randomized phase IIB ARCTIC trial of low dose Rituximab in previously untreated CLL

by Howard, DR, Munir, T, McParland, L, Rawstron, AC, Milligan, D, Schuh, A, Hockaday, A, Allsup, DJ, Marshall, S, Duncombe, AS, O’Dwyer, JL, Smith, AF, Longo, R, Varghese, A, Hillmen, P
Published 2017

Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLL

by Howard, D R, Munir, T, McParland, L, Rawstron, A C, Milligan, D, Schuh, A, Hockaday, A, Allsup, D J, Marshall, S, Duncombe, A S, O'Dwyer, J L, Smith, A F, Longo, R, Varghese, A, Hillmen, P
Published in Leukemia (2017)

Low immunoglobulin levels increase the risk of severe hypogammaglobulinemia in granulomatosis with polyangiitis patients receiving rituximab

by Besada, Emilio
Published 2016

Low immunoglobulin levels increase the risk of severe hypogammaglobulinemia in granulomatosis with polyangiitis patients receiving rituximab

by Besada, Emilio
Published in BMC Musculoskeletal Disorders (2016)

Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLL

by Howard, D. R., Munir, T., McParland, L., Rawstron, A. C., Milligan, D., Schuh, A., Hockaday, A., Allsup, D. J., Marshall, S., Duncombe, A. S., Smith, A. F., Longo, R., Varghese, A., Hillmen, P., O'Dwyer, J. L.
Published in Leukemia (2017)

Increased risk of inflammatory bowel disease among patients treated with rituximab in Iceland from 2001 to 2018.

by Kristjánsson, Valdimar B, Lund, Sigrún H, Gröndal, Gerður, Sveinsdóttir, Signý V, Agnarsson, Hjálmar R, Jónasson, Jón G, Björnsson, Einar S
Published in Scandinavian Journal of Gastroenterology (2021)

Risk Factors and Adverse Events Poorly Predict Infections and Hypogammaglobulinemia in Granulomatosis with Polyangiitis Patients Receiving Rituximab

by Besada, Emilio
Published in Autoimmune Diseases (2016)

Risk Factors and Adverse Events Poorly Predict Infections and Hypogammaglobulinemia in Granulomatosis with Polyangiitis Patients Receiving Rituximab

by Emilio Besada
Published in Autoimmune Diseases (2016)

Risk Factors and Adverse Events Poorly Predict Infections and Hypogammaglobulinemia in Granulomatosis with Polyangiitis Patients Receiving Rituximab

by Emilio Besada
Published in Autoimmune Diseases (2016)

Increased risk of inflammatory bowel disease among patients treated with rituximab in Iceland from 2001 to 2018

by Kristjánsson, Valdimar B., Lund, Sigrún H., Gröndal, Gerður, Sveinsdóttir, Signý V., Agnarsson, Hjálmar R., Jónasson, Jón G., Björnsson, Einar S.
Published in Scandinavian Journal of Gastroenterology (2020)

Rheumatoid arthritis therapy with genetically engineered biological agents in the Republic of Karelia

by Irina Mikhailovna Marusenko, И. М. Марусенко
Published in Modern Rheumatology Journal (2013)

Clinical significance of DNA methylation in chronic lymphocytic leukemia patients:Results from 3 UK clinical trials

by Wojdacz, Tomasz K., Amarasinghe, Harindra E., Kadalayil, Latha, Beattie, Alice, Forster, Jade, Blakemore, Stuart J., Parker, Helen, Bryant, Dean, Larrayoz, Marta, Clifford, Ruth, Robbe, Pauline, Davis, Zadie A., Else, Monica, Howard, Dena R., Stamatopoulos, Basile, Steele, Andrew J., Rosenquist, Richard, Collins, Andrew, Pettitt, Andrew R., Hillmen, Peter, Plass, Christoph, Schuh, Anna, Catovsky, Daniel, Oscier, David G., Rose-Zerilli, Matthew J.J., Oakes, Christopher C., Strefford, Jonathan C.
Published in Blood Advances (2019)

Burkholderiaceae Are Key Acetate Assimilators During Complete Denitrification in Acidic Cryoturbated Peat Circles of the Arctic Tundra

by Hetz, Stefanie A., Horn, Marcus A.
Published 2021

Langvinnt eitilfrumuhvítblæði á Íslandi 2003-2016: Lifun, lyfja- og blóðhlutameðferð

by Hrafn Hlíðdal Þorvaldsson 1993-
Published 2017

Case report: Anti-CNTN1 antibody-associated nodopathies disease with asymmetric onset

by Li, Qian, Chen, Qing, Zhang, Ting, Xu, Ying, Kan, Yanmin, Zhang, Jing
Published in Frontiers in Neurology (2023)